LobbyingTivity Health lobbying by quarter
Tivity Health's latest lobbying report covers Q2 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Tivity Health
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues9 reports
- Medicare and Medicaid9 reports
A report that names several issues counts once for each.
Who was lobbied
- Health & Human Services, Dept of (HHS)8 reports
- HOUSE OF REPRESENTATIVES8 reports
- SENATE8 reports
Firms it paid
| Firm | ||
|---|---|---|
| Alston & Bird | $480K | 11 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ADAM NAVARA | Legislative Fellow, Rep. Jan Schakowsky. | Q4 2024 |
| Y. BRIAN LEE | Legislative Intern, Rep. Doug Lamborn. | Q4 2024 |
| ELINOR HILLER | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. | Q3 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/07/21for Q2 2025 | Alston & Bird | Under $5,000 |
| 25/04/21for Q1 2025 | Alston & Bird | Under $5,000 |
| 25/01/21for Q4 2024 | Alston & Bird | $50K |
| 24/10/21for Q3 2024 | Alston & Bird | $10K |
| 24/07/22for Q2 2024 | Alston & Bird | $60K |
| 24/04/22for Q1 2024 | Alston & Bird | $60K |
| 24/01/22for Q4 2023 | Alston & Bird | $60K |
| 23/10/20for Q3 2023 | Alston & Bird | $60K |
| 23/07/20for Q2 2023 | Alston & Bird | $60K |
| 23/04/20for Q1 2023 | Alston & Bird | $60K |
| 23/01/20for Q4 2022 | Alston & Bird | $60K |